Analytical evaluation of point-of-care procalcitonin (PCT) and clinical performances in an unselected population as compared with central lab PCT assay
- 26 July 2017
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 55 (8) , e167-e171
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- ProcalcitoninJournal of Clinical Pathology, 2015
- Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapyAnnals of Intensive Care, 2013
- Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and futureBMC Medicine, 2011
- Procalcitonin Algorithms for Antibiotic Therapy DecisionsArchives of internal medicine (1960), 2011
- Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor® SystemClinical Chemistry and Laboratory Medicine (CCLM), 2004
- The clinical features of severe community-acquired pneumonia presenting as septic shockJournal of Critical Care, 2000
- Measuring agreement in method comparison studiesStatistical Methods in Medical Research, 1999
- Quality of Care, Process, and Outcomes in Elderly Patients With PneumoniaJAMA, 1997
- The meaning of kappa: Probabilistic concepts of reliability and validity revisitedJournal of Clinical Epidemiology, 1996
- High serum procalcitonin concentrations in patients with sepsis and infectionThe Lancet, 1993